201 related articles for article (PubMed ID: 16225507)
1. Revisiting my personal decision about prostate-specific antigen testing in 2005.
Barry MJ
BJU Int; 2005 Nov; 96(7):954-6. PubMed ID: 16225507
[No Abstract] [Full Text] [Related]
2. [Screening for prostate cancer: results from the first screening round in the French population of the ERSPC trial].
Richard F
Prog Urol; 2009 Jul; 19(7):499-500. PubMed ID: 19559381
[No Abstract] [Full Text] [Related]
3. Best screening tests for prostate cancer.
Moul JW
West J Med; 1998 Aug; 169(2):109-10. PubMed ID: 9735692
[No Abstract] [Full Text] [Related]
4. Early stage prostate cancer--do we have a problem with over-detection, overtreatment or both?
Carroll PR
J Urol; 2005 Apr; 173(4):1061-2. PubMed ID: 15758699
[No Abstract] [Full Text] [Related]
5. Application of prostate-specific antigen in prostate cancer.
Liang SL
MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
[No Abstract] [Full Text] [Related]
6. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
[TBL] [Abstract][Full Text] [Related]
7. A risk-stratified approach to prostate-specific antigen screening.
Keto CJ; Freedland SJ
Eur Urol; 2011 Apr; 59(4):506-8. PubMed ID: 21292387
[No Abstract] [Full Text] [Related]
8. Guideline of guidelines: prostate cancer screening.
Loeb S
BJU Int; 2014 Sep; 114(3):323-5. PubMed ID: 24981126
[No Abstract] [Full Text] [Related]
9. [Based on current knowledge the introduction of the PSA screening for prostatic cancer is unethical].
Krantz I; Sachs L; Ahlberg BM; Nordin P; Nilstun T
Lakartidningen; 2005 Sep 5-11; 102(36):2498-500. PubMed ID: 16196436
[No Abstract] [Full Text] [Related]
10. PSA: prostate-specific antigen, persisting scientific ambiguities.
Harv Mens Health Watch; 2009 Jul; 13(12):1-6. PubMed ID: 19718841
[No Abstract] [Full Text] [Related]
11. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.
Höltl W; Lunglmayr G
Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868
[No Abstract] [Full Text] [Related]
12. Screening for prostate cancer - will we ever know?
Adolfsson J
Acta Oncol; 2010 Apr; 49(3):275-7. PubMed ID: 20397764
[No Abstract] [Full Text] [Related]
13. Prostate specific antigen testing for the diagnosis of prostate cancer.
McKenzie P; Delahunt B; deVoss K; Ross B; Tran H; Sikaris K
Pathology; 2011 Aug; 43(5):403. PubMed ID: 21753713
[No Abstract] [Full Text] [Related]
14. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
[No Abstract] [Full Text] [Related]
15. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
Ito K
Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
[No Abstract] [Full Text] [Related]
16. [PSA based screening for prostatic cancer].
Johansen TE
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
[No Abstract] [Full Text] [Related]
17. [Elevated PSA--what to do?].
Machemer H; Rohde D
MMW Fortschr Med; 2008 Oct; 150(44):38-9. PubMed ID: 19024490
[No Abstract] [Full Text] [Related]
18. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
19. [Legal (liability) aspects of PSA determination].
Mielke K
Urologe A; 2006 Jun; 45(6):756-65. PubMed ID: 16788794
[No Abstract] [Full Text] [Related]
20. [Comments on the PSA in primary health care: survey results in more "losers" than "winners"].
Bratt O
Lakartidningen; 2003 Nov; 100(48):4014-5. PubMed ID: 14717100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
